ASRT
ASRT
NASDAQ · Pharmaceuticals

Assertio Holdings Inc

$22.17
+0.01 (+0.05%)
As of May 9, 2:07 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +8.1% upside
Low Target $13.92
Average Target $23.96
High Target $25.97
Current Price $22.17
Current
$22.17
Target
$23.96
$13.92 $23.96 avg $25.97
Scenario Analysis
Bear Case
$13.92
-37.2%
Low target
Base Case
$23.96
+8.1%
Avg target
Bull Case
$25.97
+17.1%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$22.50
-1.5% from high
52-Week Low
$8.61
+157.5% from low
Target vs 52W High
$23.96
+6.5% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-1.89
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%